An interview with Dr Andrea Spezzi, Chief Medical Officer of Orchard Therapeutics Orchard Therapeutics is a biotechnology company funded in November 2015 as part of a partnership with leading research centres, including University College London (UCL) and Great Ormond Street Hospital (GOSH); University California Los Angeles (UCLA) and Boston Children Hospital (BCH), Harvard. Orchard’s missionaaa

On 1st July, Innovation Forum KCL hosted the Future of Science Innovation: building collaborations between academia, start-ups and industry at Bush House, The Strand. This event brought together start-up founders, academics, corporates and policymakers to discuss how start-up-industry collaborations can be successfully initiated and maintained to drive innovation. The event commenced with a panel discussion,aaa

On 11th May, Innovation Forum partnered with Johnson & Johnson Innovation and One HealthTech to host the screening of She Started It at the Institute of Child Health in London. She Started It is a documentary following five trailblazing young female founders and their journeys of entrepreneurship through the tech world. The film screening wasaaa

On 25th March, Innovation Forum KCL, alongside KCL’s Entrepreneurship Institute and Health & Life Sciences Enterprise Committee, hosted the Advancing Innovation in Healthcare: Idea Workshop at the KCL’s Waterloo Campus at KCL’s Waterloo Campus, sponsored by Founders Factory. The whole-day workshop was attended by 21 participants. The participants were organised into five teams that then developed ideasaaa

Imperial College London Innovation Forum hosted the “Innovations towards a sustainable future” event on the evening of 22nd February at Imperial’s Kensington Campus. The event was aimed at informing academics and entrepreneurs on the status of CleanTech globally, and to what extent London and the UK are involved in this sector, with examples from invitedaaa

We live in a time where climate change is at the forefront of the political agenda, constantly taking action towards decreasing the carbon footprint for a more sustainable future. Countries like China, aim to spend up to 361 billion on renewable energies by 2020. Similarly, companies are taking on corporate responsibility. Research is focusing onaaa

On the evening of 11th October, leading experts from academia and industry, with entrepreneurs, investors and policymakers, convened to discuss the emergence of the synthetic biology era.  The conference, hosted by UCL Innovation Forum and held at the Institute of Child Health, saw hundreds of attendees garnering information from experts on the current knowledge andaaa

Synthetic Biology is the use of engineering to design and construct biological parts and systems in order to address current major challenges, including applications in the fields of environmental sciences, nutrition, cleantech and biotech. In 2012, the UK Government identified Synthetic Biology as one of the seven emerging technologies of the future with strong growthaaa

Join the global IMAGINE IF! network of Innovators across 16 branches world wide, competing for the non-dilutive $30,000 award. The participation is free, don’t miss this opportunity and apply now! Registration deadline for local finals will vary. If you miss your local deadline you can still apply through the independent stream by the 14th of July 2016. Innovation Forum’s London branch invites you to theaaa

The 14th of April was a special evening at Imperial College London. More than 300 students, academics, entrepreneurs and industry professionals gathered together to learn a bit more about the future of artificial intelligence (AI) and the innovations we can expect in the years to come. Automatic Computer Assisted Medicine, Automatic Personal Assistants (PA), AIaaa